Stephen Tulipano

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Stephen Tulipano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Tulipano:

Company Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Former CFO Restricted Stock Units 40,000 $631,200 $15.78 27 Mar 2024 Direct
Stoke Therapeutics, Inc. Former CFO Common Stock 20,746 $126,522 $6.10 19 Mar 2024 Direct
Stoke Therapeutics, Inc. Former CFO Employee Stock Option (Right to Buy) 60,000 27 Mar 2024 Direct

Insider Reports Filed by Stephen Tulipano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 27 Mar 2024 2 $0 4 Former CFO 07 Jun 2024, 16:35
STOK Stoke Therapeutics, Inc. 15 Mar 2024 3 -$25,102 4 CFO 19 Mar 2024, 20:36
STOK Stoke Therapeutics, Inc. 01 Dec 2023 4 $0 4 CFO 05 Dec 2023, 16:20
STOK Stoke Therapeutics, Inc. 15 Mar 2023 2 $0 4 CFO 17 Mar 2023, 16:36
STOK Stoke Therapeutics, Inc. 07 Dec 2022 1 $0 4 CFO 09 Dec 2022, 16:13
STOK Stoke Therapeutics, Inc. 02 Jun 2022 2 +$49,997 4 CFO 03 Jun 2022, 17:00
STOK Stoke Therapeutics, Inc. 15 Mar 2022 1 $0 4 CFO 17 Mar 2022, 17:17